Karel Pacák
- Surgery top 0.1%
- Endocrinology, Diabetes and Metabolism top 0.05%
- Cancer Research top 0.1%
- Neurology top 0.5%
- Epidemiology top 2%
- Co-authors
- Graeme EisenhoferJacques W.M. LendersMassimo MannelliDavid TaïebAnne‐Paule Gimenez‐RoqueploMitsuhide NaruseM. Hassan MuradStefan K. Grebe
- Topics
- Adrenal and Paraganglionic Tumors (148 papers)Cancer, Hypoxia, and Metabolism (122 papers)Pituitary Gland Disorders and Treatments (72 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Karel Pacák
195 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Surgery 8.2k
- Endocrinology, Diabetes and Metabolism 7.0k
- Cancer Research 5.2k
- Neurology 1.8k
- Epidemiology 1.4k
Countries citing papers authored by Karel Pacák
This map shows the geographic impact of Karel Pacák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Pacák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Pacák more than expected).
Fields of papers citing papers by Karel Pacák
This network shows the impact of papers produced by Karel Pacák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Pacák. The network helps show where Karel Pacák may publish in the future.
Co-authorship network of co-authors of Karel Pacák
This figure shows the co-authorship network connecting the top 25 collaborators of Karel Pacák. A scholar is included among the top collaborators of Karel Pacák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Pacák. Karel Pacák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | Personalized Management of Pheochromocytoma and Paragangliomabreakdown → | 200 |
| 8 | 35 | |
| 9 | 7 | |
| 10 | 4 | |
| 11 | 67 | |
| 12 | 16 | |
| 13 | 180 | |
| 14 | 254 | |
| 15 | 113 | |
| 16 | 88 | |
| 17 | 15 | |
| 18 | 99 | |
| 19 | 89 | |
| 20 | Stress : basic mechanisms and clinical implications | 91 |
About Karel Pacák
Karel Pacák is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Surgery, having authored 205 papers that have together received 11.4k indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (148 papers), Cancer, Hypoxia, and Metabolism (122 papers) and Pituitary Gland Disorders and Treatments (72 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.0k citations), Cancer Research (5.2k citations) and Surgery (8.2k citations). Karel Pacák has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Graeme Eisenhofer, Jacques W.M. Lenders, Massimo Mannelli, David Taïeb, Anne‐Paule Gimenez‐Roqueplo, Mitsuhide Naruse, M. Hassan Murad, Stefan K. Grebe, William F. Young and Quan‐Yang Duh. Their work appears in journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.